All about SARM ACP-105
ACP-105 is a compound created in the laboratories of the Swedish company Acadia Pharmaceuticals in 2009, and has been the subject of numerous studies highlighting its properties and potential applications. Specifically, ACP-105 binds to the androgen receptor more effectively than DHT, suggesting its potential efficacy as a SARM (Selective Androgen Receptor Modulator). ACP-105 is a […]
